tiprankstipranks
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data
Company AnnouncementsAlpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data
10d ago
6K
DRTS
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW
PremiumTipRanks Newswire
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW
10d ago
DRTS
Alpha Tau price target raised to $9 from $7 at Citi
PremiumThe Fly
Alpha Tau price target raised to $9 from $7 at Citi
1M ago
DRTS
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses
PremiumRatings
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses
1M ago
DRTS
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year
PremiumCompany Announcements
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year
1M ago
6K
DRTS
Alpha Tau downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyAlpha Tau downgraded to Neutral from Overweight at Piper Sandler
1M ago
DRTS
DRTS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
DRTS Earnings this Week: How Will it Perform?
1M ago
DRTS
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS)
Premium
TipRanks Newswire
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS)
1M ago
DRTS
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
PremiumThe Fly
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
1M ago
DRTS
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy
PremiumCompany Announcements
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy
1M ago
6K
DRTS
Alpha Tau announces Japan’s MHLW granted marketing approbal for Alpha DaRT
PremiumThe Fly
Alpha Tau announces Japan’s MHLW granted marketing approbal for Alpha DaRT
1M ago
DRTS
Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy
PremiumCompany Announcements
Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy
2M ago
6K
DRTS
Alpha Tau issues letter to shareholders
PremiumThe FlyAlpha Tau issues letter to shareholders
2M ago
DRTS
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
Premium
Company Announcements
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
3M ago
6K
DRTS
Alpha Tau announces release of final results from study of Alpha DaRT
Premium
The Fly
Alpha Tau announces release of final results from study of Alpha DaRT
3M ago
DRTS
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical
PremiumRatings
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical
3M ago
DRTS
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy
PremiumCompany Announcements
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy
3M ago
6K
DRTS
Alpha Tau submits PMA module to FDA for Alpha DaRT
PremiumThe Fly
Alpha Tau submits PMA module to FDA for Alpha DaRT
3M ago
DRTS
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
PremiumCompany Announcements
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
4M ago
DRTS
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference
PremiumCompany AnnouncementsAlpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference
4M ago
6K
DRTS
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
Premium
Company Announcements
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
4M ago
DRTS
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
Premium
Company Announcements
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
4M ago
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >